Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer
Pierceall, William E., PhD, Sprott, Kam M., PhD, Heikkinen, Tuomas, MSc, Heikkila, Paivi, MD, PhD, Alaparthi, Lakshmi, PhD, Aittomaki, Kristiina, MD, PhD, Al-Adhami, Mohammed, PhD, Villegas-Bergazzi, Vivian, MS, Meyer, Jane L., CT, ASCP, Kutok, Jeffery L., MD, PhD, Bartkova, Jirina, MD, PhD, Bartek, Jiri, MD, PhD, Nevanlinna, Heli, PhD, Weaver, David T., PhD, Blomqvist, Carl, MD, PhD
Published in Human pathology (01.09.2012)
Published in Human pathology (01.09.2012)
Get full text
Journal Article